| Year |
Title |
Altmetric |
| 2023
|
Molecular Characterization of Visible Low Grade Dysplastic lesions in Patients with Inflammatory Bowel disease..
Human Pathology.
2023
|
|
| 2023
|
Identification of androgen response-related lncRNAs in prostate cancer
2023
|
|
| 2022
|
A high-resolution 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions.
EMBO Molecular Medicine.
14.
2022
|
|
| 2022
|
African Ancestry–Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.
Cancer Discovery.
12:2530-2551.
2022
|
|
| 2022
|
Developing 3D Organoid Raft Cultures from Patient-Derived Xenografts as Rapid Models to Screen Efficacy of Experimental Therapeutics.
International Journal of Molecular Sciences.
23.
2022
|
|
| 2022
|
A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients.
Journal of Gastrointestinal Oncology.
13:2282-2292.
2022
|
|
| 2022
|
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors.
JCI Insight.
7.
2022
|
|
| 2022
|
Neoadjuvant modified FOLFIRINOX or gemcitabine-nab paclitaxel followed by stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer and borderline pancreatic inoperable cancers..
Journal of Clinical Oncology.
40:e16253-e16253.
2022
|
|
| 2022
|
Reducing regorafenib toxicity by combining with dual JAK-HDAC inhibitor in colorectal cancer..
Journal of Clinical Oncology.
40:e15597-e15597.
2022
|
|
| 2022
|
Meta-analysis of the robustness of COVID-19 diagnostic kit performance during the early pandemic.
BMJ Open.
12.
2022
|
|
| 2022
|
DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β-catenin pathway in colorectal cancer.
Molecular Oncology.
16:1728-1745.
2022
|
|
| 2022
|
UALCAN: An update to the integrated cancer data analysis platform.
Neoplasia.
25:18-27.
2022
|
|
| 2022
|
Understanding the significance of biological clock and its impact on cancer incidence.
Cancer Letters.
527:80-94.
2022
|
|
| 2022
|
Gastrointestinal Manifestations of COVID-19 Infection: Clinicopathologic Findings in Intestinal Resections Performed at Single Institution.
Frontiers in Medicine.
9.
2022
|
|
| 2022
|
GLI1-targeting drugs induce replication stress and homologous recombination deficiency and synergize with PARP-targeted therapies in triple negative breast cancer cells
2022
|
|
| 2022
|
The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity.
Translational Oncology.
16.
2022
|
|
| 2022
|
Age-Dependent Heterogeneity of Lymph Node Metastases and Survival Identified by Analysis of a National Breast Cancer Registry.
2022
|
|
| 2022
|
Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation–Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.
Gastroenterology.
162:193-208.
2022
|
|
| 2021
|
Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells.
Scientific Reports.
11.
2021
|
|
| 2021
|
Corrigendum to ‘Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model’ [Translational Oncology 13 (2020) 100754] (Translational Oncology (2020) 13(4), (S1936523320301030), (10.1016/j.tranon.2020.100754)).
Translational Oncology.
14.
2021
|
|
| 2021
|
Expression of MHC class I polypeptide-related sequence A (MICA) in colorectal cancer.
Frontiers in Bioscience-Landmark.
26:765-776.
2021
|
|
| 2021
|
Collagen modifying enzyme P4HA1 is overexpressed and plays a role in lung adenocarcinoma.
Translational Oncology.
14.
2021
|
|
| 2021
|
Gastric Sclerosing Epithelioid Fibrosarcoma Harboring a Rare FUS-CREM Fusion.
International Journal of Surgical Pathology.
29:565-570.
2021
|
|
| 2021
|
Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent.
Cancer Medicine.
10:5712-5720.
2021
|
|
| 2021
|
Abstract LB245: TRIM29 mediates metastasis though hypoxia-regulated proteins in microsatellite-stable and p53-mutated colorectal cancers.
Cancer Research.
81:lb245-lb245.
2021
|
|
| 2021
|
Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women.
Translational Oncology.
14.
2021
|
|
| 2021
|
Age-dependent heterogeneity of lymph node metastases and survival identified by analysis of a national breast cancer registry
2021
|
|
| 2021
|
Meta-Analysis of Robustness of COVID-19 Diagnostic Kits During Early Pandemic.
2021
|
|
| 2021
|
ARID1A-mutant and deficient bladder cancer is sensitive to EZH2 pharmacologic inhibition
2021
|
|
| 2021
|
Expression of trefoil factor 3 is decreased in colorectal cancer
2021
|
|
| 2021
|
Optimum health and inhibition of cancer progression by microbiome and resveratrol.
Frontiers in Bioscience-Landmark.
26:496-517.
2021
|
|
| 2021
|
Positive Retrospective SARS-CoV-2 Testing in a Case of Acute Respiratory Distress Syndrome of Unknown Etiology..
Case Reports in Pulmonology.
2021.
2021
|
|
| 2020
|
TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.
Molecular Oncology.
14:3007-3029.
2020
|
|
| 2020
|
Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles.
Frontiers in Genetics.
11.
2020
|
|
| 2020
|
Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer.
Frontiers in Immunology.
11.
2020
|
|
| 2020
|
Re: Therapeutically Actionable PAK4 is Amplified, Overexpressed, and Involved in Bladder Cancer Progression.
Investigative urology.
204:622-623.
2020
|
|
| 2020
|
Cirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literature..
Hepatic Oncology.
8:HEP28.
2020
|
|
| 2020
|
PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression.
Translational Oncology.
13.
2020
|
|
| 2020
|
Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells
2020
|
|
| 2020
|
A quantitative centrosomal amplification score predicts local recurrence of ductal carcinoma in situ.
Clinical Cancer Research.
26:2898-2907.
2020
|
|
| 2020
|
Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.
Oncogene.
39:4077-4091.
2020
|
|
| 2020
|
Identification of distinct heterogenic subtypes and molecular signatures associated with african ancestry in triple negative breast cancer using quantified genetic ancestry models in admixed race populations.
Cancers.
12.
2020
|
|
| 2020
|
PAICS, a purine nucleotide metabolic enzyme, is involved in tumor growth and the metastasis of colorectal cancer.
Cancers.
12.
2020
|
|
| 2020
|
Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model.
Translational Oncology.
13.
2020
|
|
| 2019
|
Inclusiveness and ethical considerations for observational, translational, and clinical cancer health disparity research.
Cancer.
125:4452-4461.
2019
|
|
| 2019
|
Gain of function in somatic TP53 mutations is associated with immune-rich breast tumors and changes in tumor-associated macrophages.
Molecular Genetics and Genomic Medicine.
7.
2019
|
|
| 2019
|
MTHFD1L, A Folate Cycle Enzyme, Is Involved in Progression of Colorectal Cancer.
Translational Oncology.
12:1461-1467.
2019
|
|
| 2019
|
Therapeutically actionable PAK4 is amplified, overexpressed and involved in bladder cancer progression
2019
|
|
| 2019
|
Abstract 851: MicroRNA-124 modulated collagen-prolyl hydroxylase P4HA1 expression regulates colon cancer progression.
Cancer Research.
79:851-851.
2019
|
|
| 2019
|
Disparities in clinical outcomes across age, sex and race among patients with pancreatic adenocarcinoma: a single center experience.
Annals of Oncology.
30:iv64.
2019
|
|
| 2019
|
Efficacy and tolerability of the combination of Liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic cancers: post-approval clinic experience.
Annals of Oncology.
30:iv74.
2019
|
|
| 2019
|
Neoadjuvant modified FOLFIRINOX or gemcitabine-nab paclitaxel followed by stereotactic body radiotherapy for patients with locally advanced pancreatic cancer.
Annals of Oncology.
30:iv67.
2019
|
|
| 2019
|
Prognostic role of androgen receptor in triple negative breast cancer: A multi-institutional study.
Cancers.
11.
2019
|
|
| 2019
|
Stereotactic body radiotherapy in locally advanced pancreatic adenocarcinoma: A single institution experience.
Annals of Oncology.
30:iv89.
2019
|
|
| 2019
|
Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells..
Medicines.
6.
2019
|
|
| 2019
|
The combined survival effect of codon 72 polymorphisms and p53 somatic mutations in breast cancer depends on race and molecular subtype.
PLoS One.
14.
2019
|
|
| 2019
|
Advances in pancreatic cancer biomarkers.
Oncology Reviews.
13:69-76.
2019
|
|
| 2018
|
Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma.
Oncotarget.
9:36836-36848.
2018
|
|
| 2018
|
Wnt receptor Frizzled 8 is a target of ERG in prostate cancer
2018
|
|
| 2018
|
Detection of BRAF V600E mutations with next-generation sequencing in infarcted thyroid carcinomas after fine-needle aspiration.
American Journal of Clinical Pathology.
150:177-185.
2018
|
|
| 2018
|
Abstract 3495: Trip13, a target of miR192, facilitates colorectal cancer progression through WNT/β-catenin signaling.
Cancer Research.
78:3495-3495.
2018
|
|
| 2018
|
Single molecule mtDNA fiber FISH for analyzing numtogenesis.
Analytical Biochemistry.
552:45-49.
2018
|
|
| 2018
|
miR-34a regulates expression of the stathmin-1 oncoprotein and prostate cancer progression.
Molecular Cancer Research.
16:1125-1137.
2018
|
|
| 2018
|
Hsp70 and gama-Semino protein as possible prognostic marker of prostate cancer.
Frontiers in Bioscience-Landmark.
23:1987-2000.
2018
|
|
| 2018
|
Prostate cancer health disparities: An immuno-biological perspective.
Cancer Letters.
414:153-165.
2018
|
|
| 2017
|
Bromoethylindole (BEI-9) redirects NF-κB signaling induced by camptothecin and TNFα to promote cell death in colon cancer cells
2017
|
|
| 2017
|
Prolonged exposure of resveratrol induces reactive superoxide species–independent apoptosis in murine prostate cells
2017
|
|
| 2017
|
Label-free detection of DNA hybridization with a compact LSPR-based fiber-optic sensor
2017
|
|
| 2017
|
Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.
Oncotarget.
8:76574-76586.
2017
|
|
| 2017
|
Molecular characterization of pro-metastatic functions of β4- integrin in colorectal cancer.
Oncotarget.
8:92333-92345.
2017
|
|
| 2017
|
Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.
Oncotarget.
8:20198-20212.
2017
|
|
| 2017
|
Resveratrol induces mitochondria-mediated, caspaseindependent apoptosis in murine prostate cancer cells.
Oncotarget.
8:20895-20908.
2017
|
|
| 2016
|
Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.
Current Colorectal Cancer Reports.
12:332-344.
2016
|
|
| 2016
|
A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer.
BMC Cancer.
16.
2016
|
|
| 2016
|
Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.
Cancer Letters.
374:304-314.
2016
|
|
| 2016
|
Targeting Hsp70: A possible therapy for cancer.
Cancer Letters.
374:156-166.
2016
|
|
| 2016
|
Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas.
2016
|
|
| 2015
|
Antitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in acolon-26 tumor-bearing mouse model in vivo.
Cancer Medicine.
4:1767-1780.
2015
|
|
| 2015
|
Abstract 2776: Codon 72 and Intron-3 polymorphisms in TP53 are risk factors for breast cancer.
Cancer Research.
2776-2776.
2015
|
|
| 2015
|
Abstract 4004: Prognostic value of miRNAs in breast cancer varies with patient race and molecular subtype.
Cancer Research.
4004-4004.
2015
|
|
| 2015
|
Abstract 4953: Molecular and cellular localization profiles of tristetraprolin in colorectal cancer: Implications for tumor progression in diverse patient populations.
Cancer Research.
4953-4953.
2015
|
|
| 2015
|
3-(2-bromoethyl)-indole inhibits the growth of cancer cells and NF-κB activation
2015
|
|
| 2015
|
Clinical implications of rabphillin-3A-like gene alterations in breast cancer.
PLoS One.
10.
2015
|
|
| 2015
|
Nanomagnetic levitation three-dimensional cultures of breast and colorectal cancers.
Journal of Surgical Research.
194:319-326.
2015
|
|
| 2015
|
IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.
Bioorganic and Medicinal Chemistry.
23:602-611.
2015
|
|
| 2015
|
Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers.
Oncotarget.
6:27763-27777.
2015
|
|
| 2014
|
Abstract C77: Tristetraprolin suppression is associated with advanced stage colorectal cancer.
Cancer Epidemiology, Biomarkers and Prevention.
23:c77-c77.
2014
|
|
| 2014
|
Abstract PR5: Prognostic value of miRNAs in breast cancer: Molecular type and patient race.
Cancer Epidemiology, Biomarkers and Prevention.
23:pr5-pr5.
2014
|
|
| 2014
|
Abstract 3820: Expression of ST6Gal-1 in colorectal cancer and patient prognosis.
Cancer Research.
3820-3820.
2014
|
|
| 2014
|
Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model.
PLoS One.
9.
2014
|
|
| 2014
|
Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs.
BMC Cancer.
14.
2014
|
|
| 2014
|
A New Robust Method for Nonlinear Regression..
Journal of Biometrics and Biostatistics.
5:211.
2014
|
|
| 2014
|
Robust Logistic and Probit Methods for Binary and Multinomial Regression..
Journal of Biometrics and Biostatistics.
5.
2014
|
|
| 2013
|
The Chemokine CXCL8 in Carcinogenesis and Drug Response..
ISRN Oncology.
2013:859154.
2013
|
|
| 2013
|
Clinical implications of microRNAs in cancer
2013
|
|
| 2013
|
Post-transcriptional processing of genetic information and its relation to cancer
2013
|
|
| 2013
|
The prognostic value of MicroRNAs varies with patient race/ethnicity and stage of colorectal cancer.
Clinical Cancer Research.
19:3955-3965.
2013
|
|
| 2013
|
Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer..
Journal of Cancer Therapy.
4:898-906.
2013
|
|
| 2013
|
Abstract 1944: Evaluation of the prognostic value of miRNA-181b and its target identification and validation in colorectal cancers..
Cancer Research.
73:1944-1944.
2013
|
|
| 2013
|
Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53
2013
|
|
| 2013
|
Socioeconomic status, p53 abnormalities, and colorectal cancer.
Journal of Gastrointestinal Oncology.
4:40-44.
2013
|
|
| 2012
|
Pseudoangiomatous stromal hyperplasia (PASH) of the breast: A series of 24 patients
2012
|
|
| 2012
|
Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable Stage III colorectal adenocarcinomas.
PLoS One.
7.
2012
|
|
| 2012
|
Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: The role of rs67491583.
Cancer Genetics.
205:25-33.
2012
|
|
| 2012
|
Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells
2012
|
|
| 2012
|
MiRNAs are stable in colorectal cancer archival tissue blocks.
Frontiers in Bioscience (Elite Edition).
4 E:1937-1940.
2012
|
|
| 2011
|
Development and progression of colorectal neoplasia.
Cancer Biomarkers.
9:235-265.
2011
|
|
| 2011
|
The biology of incipient, pre-invasive or intraepithelial neoplasia.
Cancer Biomarkers.
9:21-39.
2011
|
|
| 2011
|
Translational pathology of neoplasia.
Cancer Biomarkers.
9:7-20.
2011
|
|
| 2011
|
Development and independent validation of a prognostic assay for stage ii colon cancer using formalin-fixed paraffin-embedded tissue.
Journal of Clinical Oncology.
29:4620-4626.
2011
|
|
| 2011
|
Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer.
Journal of Hematology and Oncology.
4.
2011
|
|
| 2011
|
Abstract 2262: The prognostic value of p53 abnormalities in colorectal cancers varies based on detection methods.
Cancer Research.
71:2262-2262.
2011
|
|
| 2011
|
Erratum: Development of combination tapered fiber-optic biosensor dip probe for quantitative estimation of interleukin-6 in serum samples (Journal of Biomedical Optics (2010) 15 (067005)).
Journal of Biomedical Optics.
16.
2011
|
|
| 2010
|
Bax expression is a candidate prognostic and predictive marker of colorectal cancer..
Journal of Gastrointestinal Oncology.
1:76-89.
2010
|
|
| 2010
|
Development of combination tapered fiber-optic biosensor dip probe for quantitative estimation of interleukin-6 in serum samples.
Journal of Biomedical Optics.
15.
2010
|
|
| 2010
|
Standards for immunohistochemical imaging: A protein reference device for biomarker quantitation
2010
|
|
| 2010
|
MiRNAs as biomarkers for management of patients with colorectal cancer.
Biomarkers in Medicine.
4:761-770.
2010
|
|
| 2010
|
Prognostic value of mucin 4 expression in colorectal adenocarcinomas.
Cancer.
116:3577-3586.
2010
|
|
| 2010
|
Comparison of the predictive qualities of three prognostic models of colorectal cancer.
Frontiers in Bioscience (Elite Edition).
2 E:849-856.
2010
|
|
| 2010
|
Quantitative estimation of IL-6 in serum/plasma samples using a rapid and cost-effective fiber optic dip-probe.
Proceedings of SPIE.
7559.
2010
|
|
| 2010
|
Smad signaling is required to maintain epigenetic silencing during breast cancer progression.
Cancer Research.
70:968-978.
2010
|
|
| 2009
|
Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer.
Cancer.
115:5798-5806.
2009
|
|
| 2009
|
HIV Nef-M1 effects on colorectal cancer growth in tumor-induced spleens and hepatic metastasis.
Molecular and Cellular Pharmacology.
1:85-91.
2009
|
|
| 2009
|
Combined effects of formalin fixation and tissue processing on immunorecognition Fixation effects on immunostaining
2009
|
|
| 2009
|
Combined effects of formalin fixation and tissue processing on immunorecognition.
2009
|
|
| 2009
|
Furthering the evidence-based management of dermatologic effects of EGFR inhibitor therapy.
Current Colorectal Cancer Reports.
5:179-181.
2009
|
|
| 2009
|
Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer.
Journal of Clinical Oncology.
27:4339-4345.
2009
|
|
| 2009
|
Detection of Merkel cell polyomavirus in formalin-fixed, paraffin-embedded tissue of Merkel cell carcinoma and its correlation with prognosis..
Journal of Clinical Oncology.
27:6027.
2009
|
|
| 2009
|
Prognostic significance of VDR, DKK-1, and DKK-4 expression in colorectal cancer..
Journal of Clinical Oncology.
27:e15047.
2009
|
|
| 2009
|
Prognostic significance of p53 Codon 72 polymorphism differs with race in colorectal adenocarcinoma.
Clinical Cancer Research.
15:2406-2416.
2009
|
|
| 2009
|
Immunohistochemical expression of rabphilin -3A-like (Noc2) in normal and tumor tissues of human endocrine pancreas
2009
|
|
| 2008
|
Lynch syndrome in women less than 50 years of age with endometrial cancer.
Obstetrics and Gynecology.
111:1161-1166.
2008
|
|
| 2008
|
p53 nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior
2008
|
|
| 2008
|
Clinical significance of a novel single nucleotide polymorphism in the 5′ untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma.
Frontiers in Bioscience-Landmark.
13:1050-1061.
2008
|
|
| 2007
|
The need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis.
Cancer Informatics.
1:86-97.
2007
|
|
| 2007
|
Methionine inhibits cellular growth dependent on the p53 status of cells
2007
|
|
| 2007
|
African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: An epidemiologic review.
Cancer Biomarkers.
3:301-313.
2007
|
|
| 2007
|
Comparison of predicted probabilities of proportional hazards regression and linear discriminant analysis methods using a colorectal cancer molecular biomarker database.
Cancer Informatics.
3:115-122.
2007
|
|
| 2007
|
Predicting 5-year survival of colorectal carcinoma patients using data mining methods..
Proceedings / AMIA ... Annual Symposium. AMIA Symposium.
907.
2007
|
|
| 2007
|
Understanding racial differences in colorectal cancer aids in individualized medicine.
Future Oncology.
3:235-241.
2007
|
|
| 2006
|
Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates..
American Journal of Clinical Pathology.
126:572-579.
2006
|
|
| 2006
|
Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Archives of Pathology and Laboratory Medicine.
130:1510-1515.
2006
|
|
| 2006
|
Phenotypic expression of Bax is a predictive marker of 5-fluorouracil treatment in colorectal cancer..
Journal of Clinical Oncology.
24:3605.
2006
|
|
| 2006
|
Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates: A translational research application.
American Journal of Clinical Pathology.
126:572-579.
2006
|
|
| 2006
|
Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations
2006
|
|
| 2005
|
Keynote review: Recent advances in biomarkers for cancer diagnosis and treatment.
Drug Discovery Today: BIOSILICO.
10:965-976.
2005
|
|
| 2005
|
High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.
Cancer.
103:2163-2170.
2005
|
|
| 2005
|
Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
Cancer Biomarkers.
1:241-250.
2005
|
|
| 2004
|
Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma [2] (multiple letters).
Cancer.
101:2899.
2004
|
|
| 2004
|
Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma.
Cancer.
101:66-76.
2004
|
|
| 2004
|
Prognostic Significance of p27kip-1 Expression in Colorectal Adenocarcinomas Is Associated with Tumor Stage.
Clinical Cancer Research.
10:1743-1752.
2004
|
|
| 2003
|
MUC1 and MUC2 Expression in Pancreatic Ductal Carcinoma Obtained by Fine-Needle Aspiration.
Cancer.
99:365-371.
2003
|
|
| 2003
|
The efficacy of 9-Cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: Results of a randomized double-blind clinical trial.
Cancer Epidemiology, Biomarkers and Prevention.
12:114-119.
2003
|
|
| 2003
|
Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.
Chest.
123:181-186.
2003
|
|
| 2002
|
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
Clinical Cancer Research.
8:734-744.
2002
|
|
| 2002
|
Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: A sensitive method for assessing 5-fluorocytosine toxicity in Vitro.
Analytical Biochemistry.
301:189-199.
2002
|
|
| 2002
|
Molecular staging of colorectal cancer in African-American and caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 and p27kip-1.
International Journal of Cancer.
97:403-409.
2002
|
|
| 2001
|
Altered subcellular localization of Suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
Clinical Cancer Research.
7:3495-3503.
2001
|
|
| 2001
|
Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.
2001
|
|
| 2001
|
Molecular characterization of colorectal neoplasia in translational research.
Archives of Pathology and Laboratory Medicine.
125:91-98.
2001
|
|
| 2001
|
Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands
2001
|
|
| 2000
|
Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
Clinical Cancer Research.
6:4017-4025.
2000
|
|
| 2000
|
BC1-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
International Journal of Cancer.
89:423-430.
2000
|
|
| 2000
|
Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas..
International Journal of Cancer.
89:423-430.
2000
|
|
| 2000
|
Elevated expression of fatty acid synthase (FASE) in squamous cell cancer of the lung.
2000
|
|
| 2000
|
Immunohistochemical evaluation of global DNA methylation: Comparison with in vitro radiolabeled methyl incorporation assay
2000
|
|
| 2000
|
The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
Human Pathology.
31:482-487.
2000
|
|
| 2000
|
The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.
Human Pathology.
31:1068-1073.
2000
|
|
| 1999
|
Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma.
International Journal of Cancer.
82:424-429.
1999
|
|
| 1999
|
Evaluation of biomarker modulation by fenretinide in prostate cancer patients.
European Urology.
35:429-438.
1999
|
|
| 1999
|
Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinoma.
Investigative urology.
161:945-949.
1999
|
|
| 1999
|
Ep-CAM levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
Investigative urology.
162:1462-1466.
1999
|
|
| 1998
|
Nuclear accumulation of p53 in colorectal adenocarcinoma prognostic importance differs with race and location of the tumor.
Cancer.
83:2456-2467.
1998
|
|
| 1997
|
Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.
International Journal of Cancer.
74:346-358.
1997
|
|
| 1997
|
Re: loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.
1997
|
|
| 1997
|
The use of biomarker expression to characterize neoplastic processes
1997
|
|
